These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28255728)

  • 21. Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus- and paclitaxel-eluting stents in humans.
    Otsuka F; Vorpahl M; Nakano M; Foerst J; Newell JB; Sakakura K; Kutys R; Ladich E; Finn AV; Kolodgie FD; Virmani R
    Circulation; 2014 Jan; 129(2):211-23. PubMed ID: 24163064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early vascular healing after titanium-nitride-oxide-coated stent versus platinum-chromium everolimus-eluting stent implantation in patients with acute coronary syndrome.
    Varho V; Kiviniemi TO; Nammas W; Sia J; Romppanen H; Pietilä M; Airaksinen JK; Mikkelsson J; Tuomainen P; Perälä A; Karjalainen PP
    Int J Cardiovasc Imaging; 2016 Jul; 32(7):1031-9. PubMed ID: 27076220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angioscopic assessment of peri-stent contrast staining following drug-eluting stent implantation.
    Ishihara T; Awata M; Fujita M; Watanabe T; Iida O; Ishida Y; Nanto S; Uematsu M
    Circ J; 2014; 78(1):122-7. PubMed ID: 24189464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the endothelial coverage in everolimus and zotarolimus-eluting stents in normal, atherosclerotic, and bifurcation rabbit iliac arteries.
    Torii S; Nakazawa G; Ijichi T; Yoshikawa A; Ohno Y; Ikari Y
    Cardiovasc Interv Ther; 2018 Jan; 33(1):55-61. PubMed ID: 27822890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized comparison of acute stent malapposition between platinum-chromium versus cobalt-chromium everolimus-eluting stents.
    Kim BK; Shin DH; Kim JS; Ko YG; Choi D; Jang Y; Hong MK
    Int J Cardiovasc Imaging; 2015 Feb; 31(2):269-77. PubMed ID: 25345751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Zotarolimus- versus everolimus-eluting stents for unprotected left main coronary artery disease.
    Mehilli J; Richardt G; Valgimigli M; Schulz S; Singh A; Abdel-Wahab M; Tiroch K; Pache J; Hausleiter J; Byrne RA; Ott I; Ibrahim T; Fusaro M; Seyfarth M; Laugwitz KL; Massberg S; Kastrati A;
    J Am Coll Cardiol; 2013 Dec; 62(22):2075-82. PubMed ID: 23973699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angioscopic assessment of early phase arterial repair after paclitaxel-coated nitinol drug-eluting stent implantation in the superficial femoral artery.
    Ishihara T; Iida O; Awata M; Nanto K; Nanto S; Uematsu M
    Circ J; 2013; 77(7):1838-43. PubMed ID: 23595033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Morphological, Functional, and Biological Vascular Healing Response 6 Months After Drug-Eluting Stent Implantation: A Randomized Comparison of Three Drug-Eluting Stents.
    Nakata T; Fujii K; Fukunaga M; Shibuya M; Kawai K; Kawasaki D; Naito Y; Ohyanagi M; Masuyama T
    Catheter Cardiovasc Interv; 2016 Sep; 88(3):350-7. PubMed ID: 26526816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serial angioscopic evidence of incomplete neointimal coverage after sirolimus-eluting stent implantation: comparison with bare-metal stents.
    Awata M; Kotani J; Uematsu M; Morozumi T; Watanabe T; Onishi T; Iida O; Sera F; Nanto S; Hori M; Nagata S
    Circulation; 2007 Aug; 116(8):910-6. PubMed ID: 17684153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular response to paclitaxel-eluting nitinol self-expanding stent in superficial femoral artery lesions: post-implantation angioscopic findings from the SHIMEJI trial (Suppression of vascular wall Healing after IMplantation of drug Eluting peripheral stent in Japanese patients with the Infra inguinal lesion: serial angioscopic observation).
    Tsukiyama Y; Shinke T; Ishihara T; Otake H; Terashita D; Kozuki A; Fukunaga M; Zen K; Horimatsu T; Fujii K; Shite J; Uematsu M; Takahara M; Iida O; Nanto S; Hirata KI
    Int J Cardiovasc Imaging; 2019 Oct; 35(10):1777-1784. PubMed ID: 31201589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neointimal response to second-generation drug-eluting stents in diabetic patients with de-novo coronary lesions: intravascular ultrasound study.
    Won H; Kang TS; Hong BK; Lee S; Jeon DW; Ryu SK; Min PK; Yoon YW; Lee BK; Kwon HM; Ko YG; Jang Y
    Coron Artery Dis; 2015 May; 26(3):212-9. PubMed ID: 25426659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of 2-year outcomes between zotarolimus-eluting and everolimus-eluting new-generation cobalt-chromium alloy stents in real-world diabetic patients.
    Miyazaki T; Latib A; Panoulas VF; Miyazaki S; Costopoulos C; Sato K; Naganuma T; Kawamoto H; Daida H; Colombo A
    Catheter Cardiovasc Interv; 2015 Jul; 86(1):E11-8. PubMed ID: 25534499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angioscopic Comparison of Resolute and Endeavor Zotarolimus-Eluting Stents.
    Nishimoto Y; Matsuo K; Ueda Y; Sugihara R; Hirata A; Murakami A; Kashiwase K; Higuchi Y; Yasumura Y
    Circ J; 2016; 80(3):650-6. PubMed ID: 26794153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zotarolimus-eluting Resolute Integrity versus everolimus-eluting Xience Xpedition stents in the management of very long (>30mm) de novo coronary artery stenosis.
    Patra S; Chakraborty RN; Pande A; Banerjee S; Jena M; Mandal PC; De SK; Khan A; Das SS; Ghosh D; Nag R
    Cardiovasc Revasc Med; 2017; 18(3):160-164. PubMed ID: 28017259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atherosclerotic change at one year after implantation of Endeavor zotarolimus-eluting stent vs. everolimus-eluting stent.
    Akazawa Y; Matsuo K; Ueda Y; Nishio M; Hirata A; Asai M; Nemoto T; Wada M; Murakami A; Kashiwase K; Kodama K
    Circ J; 2014; 78(6):1428-36. PubMed ID: 24717233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and efficacy of resolute zotarolimus-eluting stents compared with everolimus-eluting stents: a meta-analysis.
    Piccolo R; Stefanini GG; Franzone A; Spitzer E; Blöchlinger S; Heg D; Jüni P; Windecker S
    Circ Cardiovasc Interv; 2015 Apr; 8(4):. PubMed ID: 25858975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterogeneous arterial healing in patients following paclitaxel-eluting stent implantation: comparison with sirolimus-eluting stents.
    Awata M; Nanto S; Uematsu M; Morozumi T; Watanabe T; Onishi T; Iida O; Sera F; Minamiguchi H; Kotani J; Nagata S
    JACC Cardiovasc Interv; 2009 May; 2(5):453-8. PubMed ID: 19463470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two-week interval optical coherence tomography: imaging evidence on neointimal coverage completion after implantation of the Endeavor zotarolimus-eluting stent.
    Nishinari M; Shimohama T; Tojo T; Shiono T; Shinagawa H; Kameda R; Aoyama N; Izumi T
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):E871-8. PubMed ID: 23873677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extensive arterial repair one year after paclitaxel-coated nitinol drug-eluting stent vs. bare-metal stent implantation in the superficial femoral artery.
    Ishihara T; Iida O; Awata M; Nanto K; Shiraki T; Okamoto S; Iida T; Fujita M; Watanabe T; Nanto S; Uematsu M
    Cardiovasc Interv Ther; 2015 Jan; 30(1):51-6. PubMed ID: 25085265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of coronary angioscopic findings 8 months after stent implantation between two kinds of biodegradable polymer-coated and one durable polymer-coated drug-eluting stent.
    Yasumura K; Shutta R; Matsunaga-Lee Y; Nakamura D; Yano M; Yamato M; Egami Y; Sakata Y; Nishino M; Tanouchi J
    Coron Artery Dis; 2021 Mar; 32(2):91-95. PubMed ID: 32976243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.